{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:09:05Z","timestamp":1771067345457,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11764-024-01628-w","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:01:46Z","timestamp":1718755306000},"page":"20-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Arm morbidity and financial difficulty in breast cancer survivors"],"prefix":"10.1007","volume":"20","author":[{"given":"Sara P.","family":"Myers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Laws","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura S.","family":"Dominici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirelle","family":"Lagendijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Grossmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Mittendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tari A.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"1628_CR1","unstructured":"Financial burden of cancer care. Cancer Trends Progress Report. Updated August 2023. National Cancer Institute, NIH, DHHS, Bethesda, MD, July 2021. Accessed March 25, 2024. https:\/\/progressreport.cancer.gov\/after\/economic_burden."},{"key":"1628_CR2","unstructured":"American Cancer Society. Out-of-pocket spending limits are crucial for cancer patients & survivors. January 4, 2022. Available at: https:\/\/www.fightcancer.org\/policy-resources\/out-pocket-spending-limits-are-crucial-cancer-patients-survivors. Accessed March 25, 2024."},{"issue":"5","key":"1628_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3322\/caac.21730","volume":"72","author":"GL Smith","year":"2022","unstructured":"Smith GL, Banegas MP, Acquati C, Chang S, Chino F, Conti RM, et al. Navigating financial toxicity in patients with cancer: a multidisciplinary management approach. CA Cancer J Clin. 2022;72(5):437\u201353. https:\/\/doi.org\/10.3322\/caac.21730.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1628_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3322\/caac.21754","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524\u201341. https:\/\/doi.org\/10.3322\/caac.21754.","journal-title":"CA Cancer J Clin"},{"key":"1628_CR5","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975\u20132017, National Cancer Institute. Bethesda, MD. https:\/\/seer.cancer.gov\/csr\/1975_2017\/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020. Accessed March 25, 2024."},{"key":"1628_CR6","doi-asserted-by":"publisher","unstructured":"Ezzo J, Manheimer E, McNeely ML, Howell DM, Weiss R, Johansson KI, et al. Manual lymphatic drainage for lymphedema following breast cancer treatment. Cochrane Database Syst Rev. 2015;2015(5):CD003475. https:\/\/doi.org\/10.1002\/14651858.CD003475.pub2","DOI":"10.1002\/14651858.CD003475.pub2"},{"issue":"1","key":"1628_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.amjsurg.2015.06.015","volume":"211","author":"MN Basta","year":"2016","unstructured":"Basta MN, Fox JP, Kanchwala SK, Wu LC, Serletti JM, Kovach SJ, et al. Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of management. Am J Surg. 2016;211(1):133\u201341. https:\/\/doi.org\/10.1016\/j.amjsurg.2015.06.015.","journal-title":"Am J Surg"},{"issue":"12","key":"1628_CR8","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1200\/JCO.2008.18.3517","volume":"27","author":"YC Shih","year":"2009","unstructured":"Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27(12):2007\u201314. https:\/\/doi.org\/10.1200\/JCO.2008.18.3517.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1628_CR9","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00520-018-4418-4","volume":"27","author":"LT Dean","year":"2019","unstructured":"Dean LT, Moss SL, Ransome Y, Frasso-Jaramillo L, Zhang Y, Visvanathan K, et al. \u201cIt still affects our economic situation\u201d: long-term economic burden of breast cancer and lymphedema. Supp Care Cancer. 2019;27(5):1697\u2013708. https:\/\/doi.org\/10.1007\/s00520-018-4418-4.","journal-title":"Supp Care Cancer"},{"issue":"2","key":"1628_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.22359\/cswhi_12_2_06","volume":"12","author":"K Pitr","year":"2021","unstructured":"Pitr K. Economic and social aspects of secondary lymphedema following treatment of breast cancer. Clinical Social Work and Health Intervention. 2021;12(2):35\u20138. https:\/\/doi.org\/10.22359\/cswhi_12_2_06.","journal-title":"Clinical Social Work and Health Intervention"},{"issue":"13\u201314","key":"1628_CR11","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/0959-8049(95)00296-0","volume":"31A","author":"S Kaasa","year":"1995","unstructured":"Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, Kvikstad A. The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer. 1995;31A(13\u201314):2260\u20133. https:\/\/doi.org\/10.1016\/0959-8049(95)00296-0.","journal-title":"Eur J Cancer"},{"issue":"2","key":"1628_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2217\/cer.14.76","volume":"4","author":"J Nguyen","year":"2015","unstructured":"Nguyen J, Popovic M, Chow E, Cella D, Beaumont JL, Chu D, et al. EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review. J Comp Eff Res. 2015;4(2):157\u201366. https:\/\/doi.org\/10.2217\/cer.14.76.","journal-title":"J Comp Eff Res"},{"issue":"2","key":"1628_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/PRS.0b013e3181aee807","volume":"124","author":"AL Pusic","year":"2009","unstructured":"Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009;124(2):345\u201353. https:\/\/doi.org\/10.1097\/PRS.0b013e3181aee807.","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"1628_CR14","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1245\/s10434-023-14711-w","volume":"31","author":"A Laws","year":"2024","unstructured":"Laws A, Lagendijk M, Grossmith S, Hughes M, Lin NU, Mittendorf EA, et al. Long-term patient-reported arm symptoms in breast cancer survivors. Ann Surg Oncol. 2024;31(3):1623\u201333. https:\/\/doi.org\/10.1245\/s10434-023-14711-w.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1628_CR15","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/annonc\/mdw433","volume":"27","author":"F Perrone","year":"2016","unstructured":"Perrone F, Jommi C, Di Maio M, Gimigliano A, Gridelli C, Pignata S, et al. The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy. Ann Oncol. 2016;27(12):2224\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdw433.","journal-title":"Ann Oncol"},{"key":"1628_CR16","unstructured":"Fayers P, Aaronson N, Bjordal K, et al. The EORTC QLQ-C30 Scoring Manual (3rd Edition). European Organization for Research and Treatment of Cancer; 2001."},{"issue":"12","key":"1628_CR17","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1080\/0284186X.2016.1191668","volume":"55","author":"ES Dylke","year":"2016","unstructured":"Dylke ES, Schembri GP, Bailey DL, Bailey E, Ward LC, Refshauge K, et al. Diagnosis of upper limb lymphedema: development of an evidence-based approach. Acta Oncol. 2016;55(12):1477\u201383. https:\/\/doi.org\/10.1080\/0284186X.2016.1191668.","journal-title":"Acta Oncol"},{"issue":"20","key":"1628_CR18","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMcp1803290","volume":"379","author":"SG Rockson","year":"2018","unstructured":"Rockson SG. Lymphedema after breast cancer treatment. N Engl J Med. 2018;379(20):1937\u201344. https:\/\/doi.org\/10.1056\/NEJMcp1803290.","journal-title":"N Engl J Med"},{"key":"1628_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.breast.2022.02.013","volume":"63","author":"M Appelgren","year":"2022","unstructured":"Appelgren M, Sackey H, Wengstrom Y, Johansson K, Ahlgren J, Andersson Y, et al. Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial. Breast. 2022;63:16\u201323. https:\/\/doi.org\/10.1016\/j.breast.2022.02.013.","journal-title":"Breast"},{"key":"1628_CR20","doi-asserted-by":"publisher","first-page":"101756","DOI":"10.1016\/j.eclinm.2022.101756","volume":"55","author":"T Reimer","year":"2023","unstructured":"Reimer T, Stachs A, Veselinovic K, Polata S, Muller T, Kuhn T, et al. Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): a randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer. EClinicalMedicine. 2023;55:101756. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101756.","journal-title":"EClinicalMedicine"},{"issue":"11","key":"1628_CR21","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamasurg.2020.3325","volume":"155","author":"SM Rosenberg","year":"2020","unstructured":"Rosenberg SM, Dominici LS, Gelber S, Poorvu PD, Ruddy KJ, Wong JS, et al. Association of breast cancer surgery with quality of life and psychosocial well-being in young breast cancer survivors. JAMA Surg. 2020;155(11):1035\u201342. https:\/\/doi.org\/10.1001\/jamasurg.2020.3325.","journal-title":"JAMA Surg"},{"issue":"3","key":"1628_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/PRS.0000000000006535","volume":"145","author":"LR Mundy","year":"2020","unstructured":"Mundy LR, Rosenberger LH, Rushing CN, Atisha D, Pusic AL, Hollenbeck ST, et al. The evolution of breast satisfaction and well-being after breast cancer: a propensity-matched comparison to the norm. Plast Reconstr Surg. 2020;145(3):595\u2013604. https:\/\/doi.org\/10.1097\/PRS.0000000000006535.","journal-title":"Plast Reconstr Surg"},{"issue":"10","key":"1628_CR23","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.bjps.2015.05.039","volume":"68","author":"KE Weichman","year":"2015","unstructured":"Weichman KE, Hamill JB, Kim HM, Chen X, Wilkins EG, Pusic AL. Understanding the recovery phase of breast reconstructions: patient-reported outcomes correlated to the type and timing of reconstruction. J Plast Reconstr Aesthet Surg. 2015;68(10):1370\u20138. https:\/\/doi.org\/10.1016\/j.bjps.2015.05.039.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"6","key":"1628_CR24","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/pon.4239","volume":"26","author":"J Boyages","year":"2017","unstructured":"Boyages J, Xu Y, Kalfa S, Koelmeyer L, Parkinson B, Mackie H, et al. Financial cost of lymphedema borne by women with breast cancer. Psychooncology. 2017;26(6):849\u201355. https:\/\/doi.org\/10.1002\/pon.4239.","journal-title":"Psychooncology"},{"issue":"1","key":"1628_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41523-021-00294-w","volume":"7","author":"D Boyce-Fappiano","year":"2021","unstructured":"Boyce-Fappiano D, Bedrosian I, Shen Y, Lin H, Gjyshi O, Yoder A, et al. Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis. NPJ Breast Cancer. 2021;7(1):87. https:\/\/doi.org\/10.1038\/s41523-021-00294-w.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"1628_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10926-009-9215-y","volume":"20","author":"SQ Fantoni","year":"2010","unstructured":"Fantoni SQ, Peugniez C, Duhamel A, Skrzypczak J, Frimat P, Leroyer A. Factors related to return to work by women with breast cancer in northern France. J Occup Rehabil. 2010;20(1):49\u201358. https:\/\/doi.org\/10.1007\/s10926-009-9215-y.","journal-title":"J Occup Rehabil"},{"issue":"3","key":"1628_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3233\/WOR-2009-0926","volume":"34","author":"E Quinlan","year":"2009","unstructured":"Quinlan E, Thomas-MacLean R, Hack T, Kwan W, Miedema B, Tatemichi S, et al. The impact of breast cancer among Canadian women: disability and productivity. Work. 2009;34(3):285\u201396. https:\/\/doi.org\/10.3233\/WOR-2009-0926.","journal-title":"Work"},{"key":"1628_CR28","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1186\/s40064-016-2300-8","volume":"5","author":"J Boyages","year":"2016","unstructured":"Boyages J, Kalfa S, Xu Y, Koelmeyer L, Mackie H, Viveros H, et al. Worse and worse off: the impact of lymphedema on work and career after breast cancer. Springerplus. 2016;5:657. https:\/\/doi.org\/10.1186\/s40064-016-2300-8.","journal-title":"Springerplus"},{"issue":"7","key":"1628_CR29","doi-asserted-by":"publisher","first-page":"e27660","DOI":"10.1002\/pbc.27660","volume":"66","author":"JM Salsman","year":"2019","unstructured":"Salsman JM, Bingen K, Barr RD, Freyer DR. Understanding, measuring, and addressing the financial impact of cancer on adolescents and young adults. Pediatr Blood Cancer. 2019;66(7):e27660. https:\/\/doi.org\/10.1002\/pbc.27660.","journal-title":"Pediatr Blood Cancer"},{"issue":"23","key":"1628_CR30","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1002\/cncr.34489","volume":"128","author":"Y Ren","year":"2022","unstructured":"Ren Y, Kebede MA, Ogunleye AA, Emerson MA, Evenson KR, Carey LA, et al. Burden of lymphedema in long-term breast cancer survivors by race and age. Cancer. 2022;128(23):4119\u201328. https:\/\/doi.org\/10.1002\/cncr.34489.","journal-title":"Cancer"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01628-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-024-01628-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01628-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:27:37Z","timestamp":1771064857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-024-01628-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1628"],"URL":"https:\/\/doi.org\/10.1007\/s11764-024-01628-w","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval for this study was given by the Dana-Farber Cancer Institute research ethics review board (Study 18\u2013214). Participants were all English-speaking adult patients with stage 0-III breast cancer treated between 2002\u20132012 who participated in the institutional cancer registry and consented in writing to further contact for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\/consent to participate"}},{"value":"EAM reports compensated service on scientific advisory boards for AstraZeneca, BioNTech, Merck, and Moderna; uncompensated service on steering committees for Bristol Myers Squibb and Roche\/Genentech; speakers honoraria and travel support from Merck Sharp & Dohme; and institutional research support from Roche\/Genentech (via SU2C grant) and Gilead. EAM also reports research funding from Susan Komen for the Cure for which she serves as a Scientific Advisor, and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. TAK reports compensated service on advisory board and speakers honoraria from Exact Sciences, and compensated service as faculty for PrecisCa cancer information service. All other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}